Literature DB >> 21703302

Examination of the stimulatory signaling potential of a channel catfish leukocyte immune-type receptor and associated adaptor.

Herman D Cortes1, Benjamin C Montgomery, Karlijn Verheijen, Erick García-García, James L Stafford.   

Abstract

Expressed by various subsets of myeloid and lymphoid immune cells, channel catfish (Ictalurus punctatus) leukocyte immune-type receptors (IpLITRs) are predicted to play a key role in the initiation and termination of teleost cellular effector responses. These type I transmembrane proteins belong to the immunoglobulin superfamily and display features of immunoregulatory receptors with inhibitory and/or stimulatory signaling potential. Expanding on our previous work, which demonstrated that putative stimulatory IpLITR-types associated with the catfish adaptor proteins IpFcRγ and FcRγ-L, this study focuses on the functional significance of this immune receptor-adaptor signaling complex. Specifically, we generated an epitope-tagged chimeric receptor construct by fusing the extracellular domain of IpLITR 2.6b with the transmembrane region and cytoplasmic tail of IpFcRγ-L. This chimera was stably expressed in a rat basophilic leukemia (RBL) cell line, RBL-2H3, and following cross-linking of the surface receptor with an anti-hemagglutinin monoclonal antibody or opsonized microspheres, the chimeric teleost receptor induced cellular degranulation and phagocytic responses, respectively. Site-directed mutagenesis of the immunoreceptor tyrosine-based activation motif encoded within the cytoplasmic tail of the chimera confirmed that these functional responses were dependent on the phosphorylated tyrosines within this motif. Using a combination of phospho-specific antibodies and pharmacological inhibitors, we also demonstrate that the IpLITR/IpFcRγ-L-induced degranulation response requires the activity of Src homology 2 domain containing protein tyrosine phosphatases, phosphatidylinositol 3-kinase, protein kinase C, and mitogen-activated protein kinases but appears independent of the c-Jun N-terminal kinase and p38 MAP kinase pathways. In addition to this first look at stimulatory IpLITR-mediated signaling and its influence on cellular effector responses, the advantage of generating RBL-2H3 cells stably expressing a functional IpLITR-adaptor chimera will be discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703302     DOI: 10.1016/j.dci.2011.06.004

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  5 in total

Review 1.  Identification of distinct LRC- and Fc receptor complex-like chromosomal regions in fish supports that teleost leukocyte immune-type receptors are distant relatives of mammalian Fc receptor-like molecules.

Authors:  Jiahui Wang; Miodrag Belosevic; James L Stafford
Journal:  Immunogenetics       Date:  2021-01-07       Impact factor: 2.846

Review 2.  Multigene families of immunoglobulin domain-containing innate immune receptors in zebrafish: deciphering the differences.

Authors:  Iván Rodríguez-Nunez; Dustin J Wcisel; Gary W Litman; Jeffrey A Yoder
Journal:  Dev Comp Immunol       Date:  2014-02-15       Impact factor: 3.636

3.  An Imaging Flow Cytometry Protocol for Studying Immunoregulatory Receptor-Mediated Regulation of Phagocytosis.

Authors:  Myron A Zwozdesky; Chenjie Fei; James L Stafford
Journal:  Methods Mol Biol       Date:  2022

4.  A Fish Leukocyte Immune-Type Receptor Uses a Novel Intracytoplasmic Tail Networking Mechanism to Cross-Inhibit the Phagocytic Response.

Authors:  Chenjie Fei; Myron A Zwozdesky; James L Stafford
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 5.  Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors.

Authors:  Chenjie Fei; Joshua G Pemberton; Dustin M E Lillico; Myron A Zwozdesky; James L Stafford
Journal:  Biology (Basel)       Date:  2016-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.